Actos and Metastatic carcinoma of the bladder - a phase IV clinical study of FDA data

Summary:

We study 48,879 people who have side effects when taking Actos. Metastatic carcinoma of the bladder is found, especially among people who are male, 60+ old, have been taking the drug for 5 - 10 years, also take Metformin and have Birth control.

The phase IV clinical study analyzes which people take Actos and have Metastatic carcinoma of the bladder. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

48,879 people reported to have side effects when taking Actos.
Among them, 111 people (0.23%) have Metastatic carcinoma of the bladder.

What is Actos?

Actos has active ingredients of pioglitazone hydrochloride. It is used in diabetes. Currently, eHealthMe is studying from 49,543 Actos users.

What is Metastatic carcinoma of the bladder?

Metastatic carcinoma of the bladder (cancer types can spread to the bladder from other place) is found to be associated with 191 drugs and 115 conditions by eHealthMe. Currently, we are studying 734 people who have Metastatic carcinoma of the bladder.

Number of Actos and Metastatic carcinoma of the bladder reports submitted per year:

Could Actos cause Metastatic carcinoma of the bladder?

Time on Actos when people have Metastatic carcinoma of the bladder *:

Click here to view

Gender of people who have Metastatic carcinoma of the bladder when taking Actos*:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Actos and have Metastatic carcinoma of the bladder?

Check whether Metastatic carcinoma of the bladder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Actos side effects by duration, gender and age:

Actos side effects (49,543 reports)

Metastatic carcinoma of the bladder treatments and more:

Metastatic carcinoma of the bladder (734 reports)

Common drugs associated with Metastatic carcinoma of the bladder:

Actos: 111 reports

All the drugs that are associated with Metastatic carcinoma of the bladder:

Metastatic carcinoma of the bladder (191 drugs)

Common conditions associated with Metastatic carcinoma of the bladder:

Type 2 diabetes: 115 reports

All the conditions that are associated with Metastatic carcinoma of the bladder:

Metastatic carcinoma of the bladder (115 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pioglitazone hydrochloride (the active ingredients of Actos) and Actos (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.